First Niagara Bank’s Pfizer PFE Stock Holding History

First Niagara Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$7.4M	Sell	221,648 -3,227	-1%	-$103K	2.11%	9
2016 Q1	$6.32M	Sell	224,875 -3,726	-2%	-$106K	1.86%	11
2015 Q4	$7M	Sell	228,601 -17,395	-7%	-$547K	1.94%	10
2015 Q3	$7.33M	Sell	245,996 -220,187	-47%	-$7.06M	1.92%	9
2015 Q2	$8.29M	Buy	466,183 +206,430	+79%	+$6.73M	1.86%	10
2015 Q1	$8.57M	Sell	259,753 -15,826	-6%	-$503K	1.89%	11
2014 Q4	$8.14M	Buy	275,579 +227	+0.1%	+$6.51K	1.74%	12
2014 Q3	$7.72M	Buy	275,352 +2,411	+0.9%	+$67.7K	1.63%	13
2014 Q2	$7.69M	Sell	272,941 -4,031	-1%	-$115K	1.59%	13
2014 Q1	$8.44M	Sell	276,972 -6,578	-2%	-$196K	1.69%	14
2013 Q4	$8.24M	Sell	283,550 -4,151	-1%	-$121K	1.59%	14
2013 Q3	$7.84M	Sell	287,701 -1,464	-0.5%	-$39.8K	1.67%	12
2013 Q2	$7.68M	Buy	+289,165	New	+$7.99M	1.62%	13

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Niagara Bank's PFE Position: Q2 2016 in Review

First Niagara Bank reduced its Pfizer (PFE) stake by 1.4% in Q2 2016, selling an estimated $103K and leaving 221,648 shares worth $7.4M. The position accounts for 2.11% of the portfolio, ranked #9.

First Niagara Bank first reported a position in PFE in Q2 2013 and has held it in 13 quarters since. The position peaked at $8.57M in Q1 2015. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

First Niagara Bank held 221,648 shares of Pfizer worth $7.4M as of Q2 2016.
First Niagara Bank sold 3,227 Pfizer shares in Q2 2016, an estimated $103K.
Pfizer made up 2.11% of First Niagara Bank's portfolio in Q2 2016, its #9 holding.
First Niagara Bank first reported a position in Pfizer in Q2 2013 and has held it in 13 quarters since.
First Niagara Bank's Pfizer position peaked at $8.57M in Q1 2015.
1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.